appwisp
  • App explorer
  • SDKs insights
  • API
  • Contact
  • About
  • API
  • Github
© 2025 appwisp.com

BHMeds-R3-UAT

com.tricension.bhmedsr3UAT

View detailed information for BHMeds-R3-UAT — ratings, download counts, screenshots, pricing and developer details. See integrated SDKs and related technical data.

Total installs
23(23)
Rating
0.0
Released
July 18, 2020
Last updated
January 14, 2021
Category
Education
Developer
Tricension
Developer details

Name
Tricension
E-mail
[email protected]
Website
unknown
Country
unknown
Address
unknown
Android SDKs

  • Android SDK
  • Xamarin
BHMeds-R3-UAT Header - AppWisp.com

Screenshots

BHMeds-R3-UAT Screenshot 1 - AppWisp.com
BHMeds-R3-UAT Screenshot 2 - AppWisp.com

Description

The BH MEDS-R3 App was developed by the Mid-America Addiction Technology Transfer Center (Mid-America ATTC) under a cooperative agreement from the Substance Abuse and Mental Health Services Administration's (SAMHSA) for use by behavioral health or allied health professionals. The App is designed as a quick reference of medications commonly prescribed in the treatment of persons with substance use disorders and/or mental health conditions. The use of this App is not intended to replace clinical consultation with a physician or other healthcare professional.
All material appearing in this App, except that taken directly from copyrighted sources, is in the public domain and may be reproduced or copied without permission from SAMHSA or the authors. Citation of the source is appreciated.
In addition the the BH MEDS R-3 App, another useful resource is SAMHSA's Treatment Improvement Protocol (TIP) 63, which reviews medications used to treat opioid use disorder (OUD). TIP 63 provides information on methadone, naltrexone, and buprenorphine, along with other strategies and services needed to support people with OUD. Click the button below to access the publication.